From September 28–30, 2026, the D-A-CH EV Meeting 2026 will take place at the Hörsaalzentrum of the Medical Faculty, University Hospital Erlangen — the first joint annual meeting of the German, Austrian and Swiss societies for extracellular vesicles (GSEV, ASEV and SwissEV). Under the motto “Extracellular Vesicles: Communication Across Barriers,” around 300 to 350 international scientists from the EV field will gather in Erlangen.
The three-day programme covers the full breadth of EV research: from the fundamentals of EV biology, purification and characterization, to methodological advances, microbial EVs, clinical translation, reproducibility and open questions in EV research, as well as novel EV sources and emerging concepts. Keynote lectures, selected abstracts, poster sessions, roundtable discussions and industry presentations will offer a broad and interactive scientific agenda, complemented by a welcome reception and a social event.
We are pleased to support the D-A-CH EV Meeting 2026 as a Silver Sponsor and to join the international EV community for three days of discussion on the latest developments in extracellular vesicle biology, technology, and applications.
TAmiRNA will also be present scientifically with two poster presentations:
- Alexandra Wagner will present “Small RNA-Seq Workflow Choice Shapes Plasma EV miRNA Profiles: A Spike-In Guided Benchmark,” systematically comparing six small RNA-seq workflows for plasma EV miRNA profiling using miND® spike-ins.
- Marianne Pultar will present “Preserving the message: Does vesicle encapsulation define the isomiR identity of secreted and circulating miRNAs,” showing that EV packaging preserves the cellular isomiR identity of secreted miRNAs.
Come visit us at the industry exhibition — we look forward to connecting with colleagues and partners from across the EV research landscape.
As a Contract Research Organization (CRO) for extracellular vesicle and microRNA biomarker research, TAmiRNA offers a full range of EV services — from EV isolation and characterization to small RNA sequencing, qPCR-based miRNA profiling, and assay development using our proprietary miND® platform. If you’re attending the meeting and would like to discuss your project, feel free to reach out to us on-site or get in touch here.
More information on the D-A-CH EV Meeting 2026: gsev.org
Leave A Comment
You must be logged in to post a comment.